Introduction
============

Approximately 2.5 -- 10 % of cross-sectional imaging studies report at least one incidental pancreatic cystic lesion (PCL) [@JR631-1] [@JR631-2]. While pre-surgical differentiation of PCLs is challenging, appropriate surveillance of pancreatic cysts with malignant potential and resection of high risk lesions are important opportunities for prevention of pancreatic adenocarcinoma. To evaluate cysts, a combination of clinical history, imaging and endoscopic ultrasound (EUS) features, cytology, and cyst fluid carcinoembryonic antigen (CEA) is used to identify mucinous cysts [@JR631-3]. This approach remains inadequate and may result in unnecessary surgery [@JR631-4]. Although operative mortality associated with pancreatic surgery has decreased, considerable morbidities still occur in approximately one-third of patients [@JR631-4] [@JR631-5].

Confocal Laser Endomicroscopy (CLE) is a promising new technology [@JR631-6]. The technique involves real-time laser-assisted microscopic imaging of tissue where the system provides tissue sequences with a high resolution facilitating in vivo histopathology [@JR631-7]. EUS-guided needle-based CLE (nCLE) is emerging as a capable technique with significant potential [@JR631-8] [@JR631-9] [@JR631-10]. Imaging data from three clinical trials is currently the reference standard for nCLE imaging [@JR631-7] [@JR631-8] [@JR631-9] [@JR631-11]. The diagnosis of either intraductal papillary mucinous neoplasms (IPMNs) or mucinous cystic neoplasms (MCNs) is indicated by the presence of finger-like papillae (specificity 100 %) and single band-like epithelium, respectively [@JR631-8] [@JR631-9] [@JR631-10]. The specificity for diagnosing serous cystadenomas (SCAs) neared 100 % when a characteristic "superficial vascular network" pattern was visualized [@JR631-8] [@JR631-9] [@JR631-10]. The criterion for diagnosis of pseudocysts (bright particles, representing inflammatory cells against a black background \[lack of epithelial lining or vascularity\]) was confirmed in a recent study [@JR631-8]. Endomicroscopy features of other rare types of PCLs including lymphoepithelial cysts, cystic-neuroendocrine tumors, retention cysts, and cystic degeneration of metastatic lesions need further characterization and validation [@JR631-8].

More recently, a prospective external validation study (33 patients; 9 with surgical histopathology) from Europe demonstrated a "substantial" global intraobserver agreement (IOA) and diagnostic accuracy of 94 % for mucinous PCLs [@JR631-8]. In contrast, in another external validation study from the United States (15 patients; 3 with surgical histopathology), the IOA was "poor" to "fair" and the mean diagnostic accuracy was 46 % for type of PCL [@JR631-12]. A notable limitation for these and other preceding studies evaluating nCLE has been the low volume (6 % to 27 %) of patients who underwent surgical resection of PCLs for the "gold-standard" in diagnostic histopathology [@JR631-7] [@JR631-8] [@JR631-9] [@JR631-10] [@JR631-11]. Another important drawback has been the absence of intraobserver reliability [@JR631-8] [@JR631-9] [@JR631-12].

Thus, we reviewed our institution's experience with EUS-guided nCLE for evaluation of PCLs to validate previously described criteria and analyze their diagnostic accuracy in differentiating mucinous from non-mucinous PCLs in a consecutive series of patients where a majority underwent surgical resection.

Methods
=======

Study design and population
---------------------------

Our Institutional Review Board approved the following study. We performed a retrospective analysis of the EUS database and included all consecutive subjects who underwent EUS-guided nCLE for evaluation of PCLs from June 2013 to December 2015. A portion of the database included subjects (n = 5) who were prospectively enrolled in the INDEX study (Comparison of confocal laser endomicroscopic IN vivo Diagnosis and EX vivo examination against surgical histopathology of cystic pancreatic lesions; ClinicalTrials.gov NCT02516488). Our criteria for using EUS-nCLE included: (a) subject age of 18 years or older, and (b) a PCL lesion size of ≥ 20 mm being evaluated for surgical removal based on recommended international consensus guidelines [@JR631-3]. Exclusion criteria were: (a) pregnancy, (b) coagulopathy, and (c) known allergy to fluorescein.

EUS-nCLE image acquisition
--------------------------

All EUS examinations were performed using a linear echoendoscope (Olympus America, Center Valley, Pennsylvania, United States). While most EUS examinations were performed with intravenous propofol based sedation under the direction of an anesthesiologist, elective intubation for protection of airway in a few high risk patients was performed at the discretion of the supervising anesthesiologist. Fluorescein (5 mL of 10 % fluorescein sodium) was intravenously injected immediately before CLE imaging. The cystic lesion was penetrated under EUS guidance using 1 passage of a 19-gauge Flex (nitinol) needle (Boston Scientific, Natick, Massachusetts, United States). The preloaded AQ-Flex nCLE miniprobe (Cellvizio, Mauna Kea Technologies, Paris, France) was then advanced through the locking device into the 19-gauge (g) needle. The tip of the probe was advanced until it opposed the intracystic epithelium. Intracystic endomicroscopic images (video) were captured for 5 to 10 minutes with permissible angulation of the 19-g needle. Next, the AQ-Flex probe was withdrawn from the 19-g needle and the locking device was removed. A syringe with negative suction was then attached to the proximal end of the 19-g needle. The cyst fluid was aspirated after acquisition of nCLE images. A quinolone (IV) was administered on the day of the procedure, then for 3 additional days (oral).

Data collection
---------------

Clinical variables of relevance including patient demographics, laboratory data, and clinical history were collected using a standardized data collection form. A radiologist (ZS) independently reviewed all cross-sectional imaging. Imaging data were compiled with those from EUS to describe: location, number, and size of the PCLs, lesion characteristics, evidence of dilation of the main pancreatic duct (MPD), and presence of communication with the MPD.

One gastroenterologist (SK) assisted by one gastrointestinal pathologist (BS), not blinded to the final diagnosis, reviewed the nCLE video records to select high yield image sequences. Since the nCLE video captures included a significant burden of low yield intracystic non-epithelial images, they were edited to shorter durations to best represent the PCL epithelium.

Interobserver agreement and intraobserver reliability
-----------------------------------------------------

Six blinded, nCLE-naïve independent observers participated in the study. Three (SE, SM, JW) had completed fellowships in advanced endoscopy, two (DC, PH) were medical pancreatologists (i. e., did not practice EUS) and one (AM) was a first year gastroenterology fellow. Teaching slides (30-slide Microsoft PowerPoint 2013; Microsoft Inc., Redmond, Washington, United States) with hand drawn schematics, nCLE images, and nCLE videos, were provided to the observers immediately preceding both phases of the interobserver agreement (IOA) study. The nCLE image videos used for the teaching sessions were different from the cases included in the study (early learning cases at our institute). The IOA study was performed in two steps with a 2-week washout ([Fig. 1](#FI631-1){ref-type="fig"}) using the same set of nCLE videos but with a different order of images.

![ Study flow chart. EUS-nCLE: endoscopic ultrasound guided needle based confocal laser endomicroscopy. IOA: interobserver agreement.](10-1055-s-0042-116491-i631ei1){#FI631-1}

The six observers independently reviewed the 26 EUS-nCLE videos (one from each patient) and categorically documented the presence or absence of the described nCLE image patterns of PCLs [@JR631-7] [@JR631-8] [@JR631-9] [@JR631-10] [@JR631-11]. These characteristics included:

\(a\) Papillae or epithelial bands: Papillae ([Fig. 2](#FI631-2){ref-type="fig"}; [Video 1](#ME631-1){ref-type="media"}) of IPMN are finger-like projections of variable length consisting of an overlying epithelium and underlying vascular core. Nuclei do not absorb fluorescein, which contributes to the darkness of the epithelium. The vascular core absorbs fluorescein and appears bright. Single or multiple epithelial bands ([Fig. 3](#FI631-3){ref-type="fig"}; [Video 2](#ME631-2){ref-type="media"}) of MCN are observed without a papillary configuration. These bands demonstrated layering or a horizon-type configuration.

![ EUS-guided needle based confocal endomicroscopy of intraductal papillary mucinous neoplasms (IPMN): "Finger-like" papillary projections representing the central fibrovascular core (black arrows) and overlying epithelium (white arrows) of the papillae. **a**, **c** In vivo EUS-nCLE imaging of branch duct IPMN. **b, d** surgical histopathology: **b**, magnification × 40; **d**, magnification × 10.](10-1055-s-0042-116491-i631ei2){#FI631-2}

![ EUS-guided needle based confocal endomicroscopy of mucinous cystic neoplasm (MCN). **a**, **b** MCN with low grade dysplasia. EUS-nCLE image (**a**) demonstrates a solitary epithelial band (white arrow) correlating with representative histology (**b**, magnification × 10). **c**, **d** MCN with high grade dysplasia. EUS-nCLE image (**c**) reveals a thicker epithelial band (white arrow) relating to representative histology (**d**, magnification × 40).](10-1055-s-0042-116491-i631ei3){#FI631-3}

**Video 1** EUS-guided needle based confocal endomicroscopy of intraductal papillary mucinous neoplasms: "Finger-like" papillary projections representing the central fibrovascular core and overlying epithelium of the papillae.

**Video 2** EUS-guided needle based confocal endomicroscopy of mucinous cystic neoplasm demonstrates multiple epithelial bands. These bands demonstrate layering or a horizon-type configuration.

\(b\) Fern-pattern of vascularity: This was previously described as a "superficial vascular network" of SCAs [@JR631-9] [@JR631-13]. In this pattern, there is a concentrated network of parallel vessels emanating from a central vessel similar to a fern-leaf ([Fig. 4](#FI631-4){ref-type="fig"}; [Video 3](#ME631-3){ref-type="media"}).

![ EUS-guided needle based confocal endomicroscopy (nCLE) in pancreatic cystic lesions. **a** Schematic diagram of the "fern-pattern" of vascularity in serous cystadenoma. **b**, **c** nCLE images of the "fern-pattern" of vascularity.](10-1055-s-0042-116491-i631ei4){#FI631-4}

**Video 3** EUS-guided needle based confocal endomicroscopy of serous cystadenoma demonstrates a concentrated network of parallel vessels emanating from a central vessel similar to a fern leaf. We termed this as "fern-pattern" vascularity. This has been called "superficial vascular network" in earlier publications.

\(c\) Bright particles against a dark background: Inflammatory cells, especially macrophages have autofluorescence and are observed as "bright particles" against a dark background ([Fig. 5 a](#FI631-5){ref-type="fig"}; [Video 4](#ME631-4){ref-type="media"}) [@JR631-14]. These are mostly seen in pseudocysts, and some MCNs with chronic inflammation. However, unlike MCNs, pseudocysts do not have any epithelial bands [@JR631-8]. Furthermore, pseudocysts demonstrate a completely dark background due to lack of a true wall and associated vascularity.

![ EUS-guided needle based confocal endomicroscopy of pancreatic cysts. **a** Pseudocysts lack an underlying epithelium and demonstrate multiple clusters of bright, floating, heterogeneous particles representing inflammatory debris and cells (autofluorescent macrophages: green arrows). Due to lack of vascularity, the background is dark. **b** Lymphoepithelial cyst revealing squamous type epithelium (orange arrows). **c** Epidermoid cyst also revealing squamous type epithelial cells (yellow arrows). **d** Lymphoepithelial cyst with abundant keratin (blue arrows).](10-1055-s-0042-116491-i631ei5){#FI631-5}

**Video 4** EUS-guided needle based confocal endomicroscopy of pseudocysts: Bright particles representing autofluorescent inflammatory macrophages set against a dark background.

\(d\) After reviewing each nCLE video, the observers also categorically documented if the cyst was a mucinous versus non-mucinous PCL. The presence of papillae or epithelial bands and the absence of a fern-pattern of vascularity or features of a pseudocyst was consistent with a mucinous PCL.

Final diagnosis
---------------

All patients had been previously discussed in multidisciplinary pancreatic tumor board conferences. A gastrointestinal pathologist (BS) reviewed surgical pathology.

A total of 20 patients underwent surgical resection ([Table 1](#TB631-1){ref-type="table"}). **Supplement 1** discusses the diagnostic details of patients without surgical histopathology (n = 6; 3 SCAs and 3 pseudocysts). For the three patients with pseudocysts, a definitive diagnosis was reached by cytology and consensus review at a multidisciplinary tumor board meeting. These patients presented with a history of alcoholism or hypertriglyceridemia or recent acute pancreatitis, and imaging studies, cyst fluid analysis, and cytology were diagnostic of pseudocysts. Furthermore, all three subjects demonstrated a decrease in size of the cyst during a follow-up of ≥ 1 year.

###### Cystic pancreatic lesions: demographics, clinical features, cyst imaging and fluid characteristics, final diagnosis, and follow-up.

       Gender   Age   History of pancreatitis   Abdominal symptoms   Size, mm   Location        MPD communication   MPD dilation   Cyst CEA, ng/dL   Final diagnosis                                                                        Evidence for diagnosis   Follow-up, days; cyst size
  ---- -------- ----- ------------------------- -------------------- ---------- --------------- ------------------- -------------- ----------------- -------------------------------------------------------------------------------------- ------------------------ ----------------------------
   1   Female   38    No                        Symptomatic          61         Tail            No                  No             733               MCN                                                                                    Surgical pathology       
   2   Female   51    Yes                       Symptomatic          41         Neck/body       No                  Yes            76                MCN                                                                                    Surgical pathology       
   3   Female   47    No                        Incidental           29         Neck/body       No                  Yes            1992              MCN[1](#FN631-1){ref-type="table-fn"}                                                  Surgical pathology       
   4   Female   47    No                        Incidental           28         Neck/body       No                  No             6512              MCN[1](#FN631-1){ref-type="table-fn"}                                                  Surgical pathology       
   5   Female   45    Yes                       Symptomatic          24         Neck/body       No                  Yes            2400              MCN[1](#FN631-1){ref-type="table-fn"}                                                  Surgical pathology       
   6   Female   51    No                        Incidental           20         Tail            No                  No             660               Retention cyst                                                                         Surgical pathology       
   7   Male     62    No                        Incidental           25         Tail            No                  No             2664              Epidermoid cyst                                                                        Surgical pathology       
   8   Male     52    No                        Incidental           31         Tail            No                  No             Thick/pasty       Lymphoepithelial                                                                       Surgical pathology       
   9   Male     42    No                        Incidental           23         Neck/body       No                  No             899               Lymphoepithelial                                                                       Surgical pathology       
  10   Female   43    Yes                       Symptomatic          28         Neck/body       No                  No             Thick/pasty       Pseudocyst                                                                             Cytology; MDC            475, decrease
  11   Male     30    Yes                       Incidental           21         Tail            No                  No             4.7               Pseudocyst                                                                             Cytology; MDC            484, decrease
  12   Female   59    Yes                       Incidental           51         Tail            No                  No             204               Pseudocyst                                                                             Cytology; MDC            380, decrease
  13   Male     49    No                        Incidental           28         Head/uncinate   No                  No             No fluid          SCA                                                                                    MDC                      398, no change
  14   Female   65    No                        Symptomatic          57         Tail            No                  No             No fluid          SCA                                                                                    MDC                      367, no change
  15   Female   31    No                        Incidental           19         Tail            No                  No             0.5               SCA                                                                                    MDC                      497, decrease
  16   Female   59    No                        Incidental           60         Tail            No                  No             0.5               SCA                                                                                    Surgical pathology       
  17   Female   57    No                        Incidental           26         Neck/body       Yes                 Yes            46                IPMN[2](#FN631-2){ref-type="table-fn"}; Gastric                                        Surgical pathology       
  18   Male     59    No                        Incidental           22         Head/uncinate   Yes                 Yes            1517              IPMN[2](#FN631-2){ref-type="table-fn"}; Intestinal[3](#FN631-3){ref-type="table-fn"}   Surgical pathology       
  19   Female   54    No                        Symptomatic          30         Head/uncinate   Yes                 Yes            Very viscous      IPMN[4](#FN631-4){ref-type="table-fn"}; Oncocytic[3](#FN631-3){ref-type="table-fn"}    Surgical pathology       
  20   Male     68    No                        Incidental           33         Tail            Yes                 No             151.4             IPMN[4](#FN631-4){ref-type="table-fn"}; Gastric                                        Surgical pathology       
  21   Male     78    No                        Symptomatic          14         Tail            Yes                 Yes            54                IPMN[2](#FN631-2){ref-type="table-fn"}; Gastric                                        Surgical pathology       
  22   Female   67    No                        Symptomatic          21         Head/uncinate   Yes                 Yes            188               IPMN[2](#FN631-2){ref-type="table-fn"}; Gastric[3](#FN631-3){ref-type="table-fn"}      Surgical pathology       
  23   Male     68    Yes                       Symptomatic          31         Neck/body       Yes                 Yes            Very viscous      IPMN[2](#FN631-2){ref-type="table-fn"}; Intestinal[3](#FN631-3){ref-type="table-fn"}   Surgical pathology       
  24   Female   75    Yes                       Symptomatic          36         Tail            Yes                 No             148               IPMN[2](#FN631-2){ref-type="table-fn"}; PB[3](#FN631-3){ref-type="table-fn"}           Surgical pathology       
  25   Male     71    No                        Incidental           40         Head/uncinate   Yes                 Yes            Very viscous      IPMN[2](#FN631-2){ref-type="table-fn"}; Intestinal[3](#FN631-3){ref-type="table-fn"}   Surgical pathology       
  26   Female   58    No                        Symptomatic          25         Tail            Yes                 No             120               IPMN[4](#FN631-4){ref-type="table-fn"}; Gastric                                        Surgical pathology       

Shading used to organize patients into diagnostic groups.MPD: Main pancreatic duct; CEA: Carcinoembryonic antigen; MCN: Mucinous cystic neoplasm; SCA: Serous cystadenoma; IPMN: Intraductal papillary mucinous neoplasm; PB: Pancreatobiliary; MDC: Multidisciplinary pancreatic tumor board conferences (imaging, patient follow-up).

MCN lesions with marked chronic inflammation.

IPMN-mixed-duct (with main duct involvement).

Presence of high grade dysplasia.

IPMN-branch duct.

###### Cystic pancreatic lesions without surgical histopathology: Demographics, clinical features, cyst imaging, EUS characteristics, final diagnosis, and follow-up.

                                  Patient                                                                                                                                                                   
  ------------------------------- -------------------------------------- ----------------------------------------------------- ------------------------------------------ ---------------- ---------------- -------------------------------------------------------
  Gender                          Female                                 Male                                                  Female                                     Male             Female           Female
  Age, years                      43                                     30                                                    59                                         49               65               31
  History of pancreatitis         Yes                                    Yes                                                   Yes                                        No               No               No
  Comorbid condition              Hypertriglyceridemia; pancreatitis     Alcoholism; pancreatitis                              Drug induced pancreatitis                                                    
  Abdominal symptoms              Symptomatic                            Incidental                                            Incidental                                 Incidental       Symptomatic      Incidental
  EUS/imaging features                                                                                                                                                                                      
  Size, mm                        28                                     21                                                    51                                         28               57               19
  Location                        Neck/body                              Tail                                                  Tail                                       Head/uncinate    Tail             Tail
  MPD communication or dilation   No                                     No                                                    No                                         No               No               No
  Compartments                     \< 2                                   \< 2                                                  \< 2                                      Microcystic      Microcystic      Microcystic
  Septation                       None                                   None                                                  None                                       Thin             Thin             Thin
  Internal debris                 Yes                                    Yes                                                   No                                         No               No               No
  Wall thickness                  No                                     Yes                                                   No                                         No               No               No
  FNA                                                                                                                                                                                                       
  Route                           Transgastric                           Transgastric                                          Transgastric                               Transduodenal    Transgastric     Transgastric
  Quantity (FNA; mL)              5                                      5                                                     30                                         No fluid         No fluid         2
  Opacity                         Cloudy/turbid                          Cloudy/turbid                                         Cloudy/turbid                              No fluid         No fluid         Clear
  Color                           Brown                                  Brown                                                 Brown                                      No fluid         No fluid         Colorless
  Cyst CEA, ng/dL                 Thick/pasty                            4.7                                                   204                                        No fluid         No fluid         0.5
  Cyst amylase, IU/dL             Thick/pasty                            10 000                                                10 000                                     No fluid         No fluid         74
  Cytology                        Amorphous, pigmented macrophages       Macrophages, calcific material, bile stained debris   Pigmented macrophages, calcific material   Non-diagnostic   Non-diagnostic   Paucicellular
  Final diagnosis                 Pseudocyst                             Pseudocyst                                            Pseudocyst                                 SCA              SCA              SCA
  Evidence for diagnosis          Cytology; MDC                          Cytology; MDC                                         Cytology; MDC                              MDC              MDC              MDC
  Follow up, days; cyst size      475, decrease                          484, decrease                                         380, decrease                              398, no change   367, no change   497, decrease
  Cyst size change                Decrease in size and number of cysts   Decreased to 6 mm                                     Decreased to 33 mm                         No change        No change        Decrease to 6 mm
  Repeat EUS-FNA                                                                                                               CEA 33.5; Amylase 20 000                                                     Cyst size 6 mm after prior aspirate; FNA not repeated

MPD: Main pancreatic duct; CEA: Carcinoembryonic antigen; SCA: Serous cystadenoma; MDC: multidisciplinary pancreatic tumor board conferences (imaging, patient follow-up).

Three subjects were diagnosed with SCA on the basis of consensus review at a multidisciplinary tumor board meeting (3 pancreatobiliary surgeons, 4 advanced endoscopists, 1 radiologist), which involved review of demographics, clinical features, cross-sectional imaging studies, and EUS characteristics, and an "uneventful follow-up \> 1 year". While the aspirate from endoscopic ultrasound guided fine needle aspiration (EUS-FNA) was of no yield (no fluid or cellularity) in two patients, one patient had a CEA of 0.5 ng/dL.

Statistical analysis
--------------------

Statistical analyses were performed using SPSS statistical package, version 21.0 (IBM Corporation, Somers, New York, United States). Continuous variables were compared with a *t* test, while categorical variables were compared with either Chi-square test or Fisher's exact test, as appropriate. Statistical significance was defined as *P* ≤ 0.05. Diagnostic accuracy parameters including area under receiver operating characteristic curve (AUC) of nCLE image patterns were calculated. The IOA for detection of nCLE image patterns was calculated using Fleiss' kappa (κ) statistic (with 95 % confidence intervals \[CI\]). The intraobserver reliability was calculated using Cohen's kappa (κ) statistic. The interpretation of κ values by Landis and Koch was used (\< 0: indicating no agreement; 0 -- 0.20: slight; 0.21 -- 0.40: fair; 0.41 -- 0.60: moderate; 0.61 -- 0.80: substantial; and 0.81 -- 1: almost perfect agreement) [@JR631-15].

Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for the detection of mucinous PCLs were calculated for each observer in both phases of the IOA study. In addition, cumulative values were calculated by averaging the results from all six observers at each phase. The cumulative values were compared for statistically significant difference using paired *t* tests.

The only variable with missing data was cyst fluid CEA ([Table 1](#TB631-1){ref-type="table"}). Multiple imputation was not performed and these data were analyzed "as is" to represent actuality. A sample size of 26 patients with three observations per patient and six independent observers would achieve an 80 % power to detect an IOA of 0.61 ("substantial" or above).

Results
=======

Study cohort
------------

A total of 49 patients underwent EUS-nCLE during the study period. A total of 26 patients (16 female; mean age 54.8 ± 12.6 years \[± standard deviation\]) had a definitive diagnosis and were selected for further study ([Fig. 1](#FI631-1){ref-type="fig"}). Mean size of PCLs was 31.7 ± 12.8 mm. Mean duration of nCLE imaging during EUS was 6.1 ± 2.8 minutes. Most cysts were located in the tail (13, 50 %), compared to the neck/body (8, 30.8 %), or head/uncinate region (5, 19.2 %). The only adverse event observed during the study was acute pancreatitis in 3/49 (6.1 %) subjects.

Demographics, clinical features, EUS findings, final diagnoses, and follow-up duration for the 26 patients are displayed in [Table 1](#TB631-1){ref-type="table"}. A pathological diagnosis was available in 23 (88.4 %) patients (surgery, n = 20; diagnostic cytology, n = 3); three patients with SCAs did not undergo surgical resection. The mean follow-up period for the six subjects (3 SCA, 3 pseudocysts) with nonsurgical management was 433.5 ± 58.1 days.

Cyst fluid CEA was available in 73.1 % (19 of 26) of patients. A total of seven subjects did not have a cyst fluid CEA available, including: patients (n = 3) with IPMN having a markedly viscous aspirate, subjects (n = 2) with a dry aspirate in the setting of an SCA, subjects with a pasty aspirate (due to pseudocyst \[n = 1\], and lymphoepithelial cyst \[n = 1\]). The sensitivity, specificity, accuracy, and AUC of cyst fluid CEA (value ≥ 192 ng/mL) for diagnosis of mucinous PCLs when available were 50 %, 43 %, 47 %, and 0.40, respectively. The sensitivity, specificity, accuracy, and AUC of cytology for diagnosis of mucinous PCLs were 53 %, 64 %, 58 %, and 0.59, respectively. An intracystic solid component was observed in 6 (23.1 %) subjects where 5 of them were IPMNs, and 1 MCN. Collectively, imaging of the cyst by MRI or EUS demonstrated thin intracystic septations in 50 % of the cysts and a communication with the MPD was observed in all IPMN patients (n = 10). High grade dysplasia was observed in 6 of 10 IPMNs and 1 of 5 MCNs that were resected. A majority (50 %) of the IPMNs resected were of the gastric subtype. Six of the 10 IPMNs resected were of the mixed-duct type while the rest were all branch-duct IPMNs.

Interobserver agreement
-----------------------

The IOA was analyzed for detection of nCLE patterns in two phases separated by a 2-week wash-out ([Table 2](#TB631-2){ref-type="table"}). In the first phase of the study, there was "substantial" IOA for detection of all nCLE-image patterns including papillae or epithelial bands, bright particles on a dark background, and fern-pattern of vascularity. The IOA for differentiating mucinous vs. non-mucinous PCL was "substantial" (κ = 0.67, 95 %CI 0.57, 0.77). In the second phase of the study, the IOAs for each of the three nCLE-image patterns improved slightly, however, without a change in the interpretation which remained at "substantial" agreement ([Table 2](#TB631-2){ref-type="table"}). The IOA for diagnosis of a mucinous PCL (κ = 0.66, 95 %CI 0.56, 0.76) remained unchanged in the second phase of the study.

###### Interobserver agreement of six observers for the detection of nCLE-image patterns and diagnosis of pancreatic cystic lesions.

                                            1^st^ phase IOA study   2^nd^ phase IOA study              
  ----------------------------------------- ----------------------- ----------------------- ---------- ------------
  **nCLE image pattern**                    Fleiss κ                95 %CI                  Fleiss κ   95 %CI
   Papillae or epithelial  bands            0.63                    0.53, 0.73              0.65       0.55, 0.75
   Dark background  with bright particles   0.71                    0.61, 0.81              0.79       0.69, 0.89
   Fern-leaf                                0.62                    0.52, 0.72              0.70       0.60, 0.80
   Mucinous cyst (IPMN  or MCN)             0.67                    0.57, 0.77              0.66       0.56, 0.76

CI: confidence interval; IOA: interobserver agreement; IPMN: intraductal papillary mucinous neoplasm; MCN: mucinous cystic neoplasm; 2nd IOA study was conducted 2 weeks (wash-out period) after the 1st study.Landis and Koch interpretation IOA and intrarater reliability: \< 0, no agreement; 0 -- 0.20, slight; 0.21 -- 0.40, fair; 0.41 -- 0.60, moderate; 0.61 -- 0.80, substantial; and 0.81 -- 1, almost perfect agreement.

Intraobserver reliability
-------------------------

The mean intraobserver reliability was "almost perfect" (κ = 0.81 ± 0.18) among EUS physicians and "substantial" among non-EUS physicians; overall the group reached "substantial" (κ = 0.78 ± 0.13) reliability for diagnosing mucinous PCLs ([Table 3](#TB631-3){ref-type="table"}). The mean intraobserver reliability was "substantial" for detection of "bright particles with dark background" (κ = 0.78 ± 0.12) and "fern-pattern" vascularity (κ = 0.68 ± 0.20). The spectrum of intraobserver reliability ranged from "substantial" to "almost perfect" for detection of "papillae" and "bright particles with dark background" while being "moderate" to "almost-perfect" for "fern-pattern" vascularity.

###### Intraobserver reliability of six observers for detection of nCLE-image patterns and diagnosis of pancreatic cystic lesions.

                                           Independent blinded nCLE-naïve observers (Cohen's κ)                                                      
  ---------------------------------------- ------------------------------------------------------ ---------------------- ------ ------ ------ ------ -------------
  **nCLE image pattern**                   *EUS physicians*                                       *Non-EUS physicians*                               
   Papillae or epithelial bands            0.91                                                   0.85                   0.64   0.69   0.68   0.77   0.76 ± 0.11
   Dark background with bright particles   0.61                                                   0.82                   0.86   0.65   0.91   0.83   0.78 ± 0.12
   Fern-pattern vascularity                1.00                                                   0.71                   0.46   0.71   0.46   0.71   0.68 ± 0.20
   Mucinous cyst (IPMN or MCN)             0.91                                                   0.92                   0.61   0.69   0.84   0.69   0.78 ± 0.13

nCLE: needle-based confocal laser endomicroscopy; SD: standard deviation; IPMN: intraductal papillary mucinous neoplasm; MCN: mucinous cystic neoplasm. 2nd phase of intraobserver (IOA) study was conducted 2 weeks (wash-out period) after the 1st study.Landis and Koch interpretation IOA and intrarater reliability: \< 0, no agreement; 0 -- 0.20, slight; 0.21 -- 0.40, fair; 0.41 -- 0.60, moderate; 0.61 -- 0.80, substantial; and 0.81 -- 1, almost perfect agreement.

Diagnosis of mucinous pancreatic cystic lesions
-----------------------------------------------

The overall cumulative sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and AUC for diagnosis of a mucinous PCL were 94 %, 82 %, 88 %, 92 %, 89 %, and 0.88, respectively. These cumulative measures of diagnostic accuracy in differentiating mucinous PCLs remained mostly unchanged in the second phase of the IOA study ([Table 4](#TB631-4){ref-type="table"}). There was no statistically significant difference comparing cumulative measures of diagnostic accuracy between physicians performing EUS vs. not (**Supplement 2**).

###### Measures of diagnostic accuracy in differentiating a mucinous pancreatic cystic lesion using EUS-guided needle based confocal laser endomicroscopy: comparison between the two phases of interobserver agreement study.

                                 Observers   Sensitivity (%)   Specificity (%)   PPV (%)   NPV (%)   Accuracy (%)   ROC
  ------------------------------ ----------- ----------------- ----------------- --------- --------- -------------- -------------
  **IOA Phase 1**                                                                                                   
   EUS physicians                1           100               100               100       100       100            1.0
                                 2           100                73                83       100        89            0.86
                                 3            93                64                78        88        81            0.79
   Non-EUS physicians            4            87                91                93        83        89            0.89
                                 5            93                73                82        89        85            0.83
                                 6            93                91                93        91        92            0.92
                                 Mean ± SD    94 ± 5            82 ± 14           88 ± 8    91 ± 7    88 ± 6        0.88 ± 0.06
  **IOA Phase 2**                                                                                                   
   EUS physicians                1            93               100               100        92        96            0.97
                                 2           100                82                88       100        92            0.91
                                 3           100                54                75       100        81            0.77
   Non-EUS physicians            4            93                82                88        90        89            0.88
                                 5            87                82                87        82        85            0.84
                                 6            93                91                93        91        92            0.92
                                 Mean ± SD   94 ± 5             82 ± 15           89 ± 8    93 ± 7    89 ± 5        0.88 ± 0.07
  *P* value: IOA Phase 1 vs. 2                1.0                0.96              0.85      0.84      0.86         1.0

SD: standard deviation; PPV: positive predictive value; NPV: negative predictive value; ROC: receiver operating characteristic curve; 2nd phase of intraobserver (IOA) study was conducted 2 weeks (wash-out period) after the 1st study.

###### Paired *t* test comparison of diagnostic parameters in differentiating mucinous pancreatic cystic lesions using nCLE patterns between EUS and non-EUS physicians.

                 *P* value
  -------------- -----------
  IOA Phase 1    
   Sensitivity   0.218
   Specificity   0.635
   Accuracy      0.856
  IOA Phase 2    
   Sensitivity   0.218
   Specificity   0.345
   Accuracy      0.173

EUS, endoscopic ultrasound; nCLE, needle-based confocal laser endomicroscopy.

EUS-nCLE findings in squamous epithelial-lined cysts
----------------------------------------------------

Collectively termed squamous epithelium-lined cysts of the pancreas, these benign cysts included lymphoepithelial cysts and epidermoid cysts ([Table 1](#TB631-1){ref-type="table"}). A flat, scale-like epithelium ([Fig. 5 b, c](#FI631-5){ref-type="fig"}) was observed in both. One of the two lymphoepithelial cysts demonstrated keratinaceous debris ([Fig. 5 d](#FI631-5){ref-type="fig"}). Neither of these cysts revealed papillae or epithelial bands.

Discussion
==========

The primary aim of our study was to validate recent diagnostic characteristics of EUS-nCLE in differentiating mucinous PCLs. We demonstrate that EUS-nCLE provides in vivo diagnostic imaging of large (≥ 20 mm) pancreatic cysts with potentially higher accuracy than the current standard of practice. Gastroenterologists with pre-trial nCLE image training who were otherwise naïve to CLE and blinded to the patient information can reliably identify these diagnostic image patterns with substantial inter- and intraobserver agreement. We included consecutive patients encompassing rare types of PCLs (squamous epithelial cysts) to best represent the referral community. To our knowledge, this is the largest study describing nCLE findings in definitively diagnosed PCLs. These promising findings require additional investigation including validation in larger multicenter studies for the application of EUS-nCLE in the management of PCLs.

A summary of current literature evaluating nCLE-guided diagnosis of PCLs is given in [Table 5](#TB631-5){ref-type="table"}. The proportion of patients with surgical histopathology in the INSPECT, DETECT, and CONTACT trials is 21.2 % (14 of 66), 6.7 % (2 of 30), and 27.3 % (9 of 33), respectively. In another recent study evaluating IOA for EUS-nCLE patterns, only 20 % (3 of 15) of patients had undergone surgical resection of PCLs. Compared to these trials, our study consisted of 77 % (20 of 26) of patients with confirmed histopathology. Moreover, all of the mucinous PCLs had diagnostic gold-standard and the only cysts without surgical histopathology were SCAs and pseudocysts where in fact surgery is not recommended.

###### Outcome, diagnostic accuracies, and risk of pancreatitis for major trials investigating role of endoscopic ultrasound guided needle based confocal laser endomicroscopy in diagnosis of pancreatic cystic lesions.

  Study title and reference   Study outcome     Patients, n   Surgery, n (%)   Sensitivity, %   Specificity, %   Accuracy, %   Pancreatitis rate, %
  --------------------------- ----------------- ------------- ---------------- ---------------- ---------------- ------------- ----------------------
  INSPECT [@JR631-13]         Neoplastic cyst   66            14 (21.2 %)      59               100              71            3
  DETECT [@JR631-7]           Mucinous cyst     30             2 (6 %)         80               100              89            6.6
  CONTACT-1 [@JR631-11]       SCA               31             7 (22.5 %)      69               100              87            3.2
  CONTACT-2 [@JR631-10]       Mucinous cyst     33             9 (27.3 %)      91                95              94            Same as CONTACT-1
  Current study (INDEX)       Mucinous cyst     26            20 (76.9 %)      94                82              89            6.1

DETECT study: High certainty (n = 18) patients included in analysis of diagnostic accuracy. SCA: Serous cystadenoma.

Based on published literature (including the current study), several conclusions can be made with regard to diagnostic nCLE-patterns of PCLs. The presence of either papillary epithelium or epithelial bands has high diagnostic accuracy for mucinous PCLs. Although pre-surgical differentiation between IPMN and MCN does not significantly impact patient management, the epithelial bands in MCNs lack a papillary conformation and sometimes demonstrate a fan-like or horizon-type layering, whereas papillae in IPMNs are complete and identified with lesser effort. Some MCNs (40 % in this series) demonstrated evidence of chronic inflammation with visualization of "bright" fluorescent inflammatory cells [@JR631-16].

For the diagnosis of SCAs, detection of the fern-pattern of vascularity (superficial vascular network) is highly specific [@JR631-8] [@JR631-9] [@JR631-13]. In the absence of this pattern, the sensitivity for diagnosis of the SCAs remains low (69 % to 75 %) [@JR631-8] [@JR631-9]. Since the epithelium of oligocystic SCAs can become denuded, they can be difficult to distinguish when the characteristic vascular pattern is not observed [@JR631-16]. The nCLE criteria for diagnosis of pseudocysts have been validated in a recent study [@JR631-8]. Pseudocysts do not have an epithelium, thus no vasculature is observed [@JR631-16]. Distinct, multiple autofluorescent inflammatory cells are observed against a dark background during nCLE.

In CONTACT-2nd phase, IOAs were "almost perfect" for vascular pattern of SCAs, "fair" for epithelial pattern of MCNs, "moderate" for papillae in IPMNs, and "perfect" for pseudocysts. The global IOA was "substantial". Our study yielded a similarly favorable IOA with "substantial" agreement for identification of epithelial and vascular image patterns and for discrimination of mucinous cysts. In addition, we conducted IOAs in two phases demonstrating overall "substantial" intraobserver reliability. Our results are in sharp contrast with a recent study where videos from 15 nCLE patients were reviewed for features that were not particularly diagnostic of a PCL type. This study, however, had multiple methodological issues including the relatively short duration of nCLE video capture (mean \< 2 minutes), only three patients with surgical histopathology, absence of evaluation for intraobserver reliability, and poor quality of nCLE images [@JR631-12].

The risk of post-procedural acute pancreatitis from the three major trials utilizing nCLE for PCLs gives us an overall rate of 4.3 % ([Table 5](#TB631-5){ref-type="table"}) [@JR631-7] [@JR631-8] [@JR631-11]. The highest risk was with the DETECT study (6.6 %) and, understandably, since the procedure involved longer needle access time for Spyglass cystoscopy and nCLE imaging. The reported risk of acute pancreatitis for 22-g and/or 25-g needles in PCLs is 2.4 % [@JR631-17]. The outer diameter of a standard 19-g needle is 1.07 mm (area 0.9 mm^2^). Comparatively, a standard 22-g needle has an outer diameter of 0.72 mm (area 0.41 mm^2^), half the area of the 19-g needle. Although studies comparing a 19-g to 22-g and/or 25-g needle for FNA of solid pancreatic lesions have not demonstrated any significant increase in the risk of post-procedural pancreatitis, this does not simulate similar risks when aspirating cystic lesions [@JR631-18] [@JR631-19]. Several theories including duration of nCLE and manipulation of the elevator or scope-torque to access other areas of the cyst have been proposed to increase the risk of pancreatitis [@JR631-7]. The risk of pancreatitis in our study was 6.1 %, including one subject who developed severe pancreatitis with extra pancreatic necrosis. However, it should be noted that this subject had a coughing spell during a critical portion of the procedure resulting in shearing injury by the needle. In the final study cohort (n = 26), patients with longer duration of image acquisition (8 ± 2.1 vs. 6.4 ± 2.7 minutes; *P* = 0.02) were at increased risk for pancreatitis. This suggests that reducing the image acquisition time to 6 minutes or less may decrease the rate of adverse events.

There are obvious limitations to our study. First and foremost, this is a retrospective study with a small sample size and this compels a larger, prospective multicenter representation and external validation for generalizability. Second, the final diagnosis of 6 PCLs was by multidisciplinary consensus. A diagnosis of a non-mucinous PCLs was reached by multidisciplinary consensus and thus surgery was not performed. These patients continue to be followed at our institute (currently \> 1 year of follow-up; **Supplement 1**). Third, only a portion of the intracystic epithelium can be sampled due to limitations at the point of needle puncture. Besides, improved technology in the CLE probes to permit utilization in a 22-g needle would permit a larger nCLE viewing area of PCLs, potentially decrease the risk of post-FNA pancreatitis, and likely translate to wider adoption by gastroenterologists. Fourth, we selected consecutive patients with cysts \> 20 mm in size and those being evaluated for surgical resection; these factors introduce a potential for significant selection bias where an enriched population is being evaluated.

In conclusion, EUS-guided nCLE is a minimally invasive procedure that can potentially improve the preoperative diagnostic performance of PCLs allowing diagnosis of mucinous cysts with improved accuracy. This technology is currently used in a small number of academic centers. There is a low, albeit present, risk of post-procedural acute pancreatitis, which we believe can be reduced by limiting the time of image acquisition. EUS-nCLE is potentially complementary and can be combined with novel cyst fluid molecular markers, and a collective strategy may need to be explored for accurate diagnosis and risk stratification of pancreatic cystic lesions.

A portion of the database (n = 5) included subjects who were prospectively enrolled in the INDEX study (Comparison of confocal laser endomicroscopic IN vivo Diagnosis and EX vivo examination against surgical histopathology of cystic pancreatic lesions; ClinicalTrials.gov NCT02516488). The INDEX study is funded by the American College of Gastroenterology pilot research grant.
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